These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 8996153)
1. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. al-Sarraf M; Martz K; Herskovic A; Leichman L; Brindle JS; Vaitkevicius VK; Cooper J; Byhardt R; Davis L; Emami B J Clin Oncol; 1997 Jan; 15(1):277-84. PubMed ID: 8996153 [TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. Wendt TG; Grabenbauer GG; Rödel CM; Thiel HJ; Aydin H; Rohloff R; Wustrow TP; Iro H; Popella C; Schalhorn A J Clin Oncol; 1998 Apr; 16(4):1318-24. PubMed ID: 9552032 [TBL] [Abstract][Full Text] [Related]
4. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Nishimura Y; Suzuki M; Nakamatsu K; Kanamori S; Yagyu Y; Shigeoka H Int J Radiat Oncol Biol Phys; 2002 May; 53(1):134-9. PubMed ID: 12007951 [TBL] [Abstract][Full Text] [Related]
5. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180 [TBL] [Abstract][Full Text] [Related]
8. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109 [TBL] [Abstract][Full Text] [Related]
10. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844 [TBL] [Abstract][Full Text] [Related]
11. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136 [TBL] [Abstract][Full Text] [Related]
12. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer]. Iwase H Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007 [TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma. Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer. Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833 [TBL] [Abstract][Full Text] [Related]
16. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study. Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [TBL] [Abstract][Full Text] [Related]
18. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Chan AT; Teo PM; Leung TW; Leung SF; Lee WY; Yeo W; Choi PH; Johnson PJ Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):569-77. PubMed ID: 7558945 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg R; Benson A J Clin Oncol; 1996 Jan; 14(1):149-55. PubMed ID: 8558190 [TBL] [Abstract][Full Text] [Related]
20. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]